SSWG
AXSM icon

Seven Springs Wealth Group’s Axsome Therapeutics AXSM Stock Holding History

Seven Springs Wealth Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,005
Closed -$339K – 82
2024
Q4 		$339K Buy
+4,005
New +$368K 0.13% 58

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Seven Springs Wealth Group's AXSM Position: Q1 2025 in Review

Seven Springs Wealth Group sold out of Axsome Therapeutics (AXSM) in Q1 2025, closing a stake of 4,005 shares — an estimated $339K sold.

Seven Springs Wealth Group first reported a position in AXSM in Q4 2024 and held it in 1 quarter. The position peaked at $339K in Q4 2024. 352 funds tracked by Wall St. Rank hold AXSM as of Q1 2025.

  • Seven Springs Wealth Group reported no remaining Axsome Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Seven Springs Wealth Group sold 4,005 Axsome Therapeutics shares in Q1 2025, an estimated $339K.
  • Seven Springs Wealth Group first reported a position in Axsome Therapeutics in Q4 2024 and held it in 1 quarter.
  • Seven Springs Wealth Group's Axsome Therapeutics position peaked at $339K in Q4 2024.
  • 352 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2025.

Based on Seven Springs Wealth Group's 13F filing for Q1 2025, filed 15 May 2025.